GSK plc ESG Investor Education Event Transcript
Hello, everyone. Thank you so much for joining our investor education event on clinical trial diversity. I'm Frannie DeFranco, a member of the Investor Relations team, and I'm honored today to introduce you to our guest speakers: Alberto Fernandez, SVP of Global Clinical Operations at GSK; and someone who many investors may already know, Dr. Kimberly Smith, SVP and Head of R&D ViiV Healthcare.
Here is our agenda for today's call. First, Alberto will provide an overview of the importance of clinical trial diversity to patients, regulators and investors, then we'll talk about the research GSK has published on this topic and how we see that supporting industry efforts in this space. Then Kim will join us to provide a case study on the benefits we saw from our applied approach in our studies for a long-acting prep with cabotegravir.
With that, let me hand it over to Alberto.
Thank you very much, Frannie, and hello, everybody, and welcome to this session in which we are going to explore the importance of clinical trial
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
